| Stage | SXI | % of rev | UFPT | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $233M | 100.00% | $174M | 100.00% | SXI ×1.34 |
| Gross profit | $103M | 44.37% | $51M | 29.27% | SXI +15.1pp |
| Operating income | $40M | 17.38% | $28M | 16.15% | SXI +1.2pp |
| Pre-tax income | $32M | 13.83% | $26M | 15.19% | UFPT +1.4pp |
| Net income | $24M | 10.39% | $21M | 11.99% | UFPT +1.6pp |
| Stage | SXI | UFPT | Gap · A − B |
|---|---|---|---|
| Revenue | $233M100.00% | $174M100.00% | SXI ×1.34 |
| Gross profit | 44.37%$103M | 29.27%$51M | SXI +15.1pp |
| Operating income | 17.38%$40M | 16.15%$28M | SXI +1.2pp |
| Pre-tax income | 13.83%$32M | 15.19%$26M | UFPT +1.4pp |
| Net income |
| 10.39%$24M |
| 11.99%$21M |
| UFPT +1.6pp |